Epigenetic Aging and Rheumatoid Arthritis

Эпигенетическое старение и ревматоидный артрит
Tracie Culp Harrison, Nandini Mukherjee
2023-09-12

DNA methylationGrimAgeepigenetic age accelerationepigenetic agingrheumatoid arthritis
This is the first known comparative assessment of the associations of epigenetic age estimates with the prevalence of rheumatoid arthritis (RA). We used data available in Gene Expression Omnibus (GSE42861) from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study. Information regarding RA diagnosis and 450K DNA methylation (DNAm) of 18- to 70-year-old participants was available. Utilizing Horvath's online DNAm Age Calculator, we determined the DNAm estimate of Telomere length (DNAmTL), Hannum's epigenetic age, Horvath's 2013 and 2018 epigenetic ages, PhenoAge, GrimAge, and the respective age-acceleration measures. The association of RA prevalence with epigenetic age measures was assessed using linear regression, adjusting for sex and smoking status. The p values were corrected for multiple testing using a false discovery rate. We identified statistically significant associations of RA with Horvath 2013 age acceleration (estimate: -1.34; FDR p value: 1.0 × 10-2), Horvath 2018 age acceleration (estimate: -1.32; FDR p value: 4.0 × 10-5), extrinsic age acceleration (estimate: 1.34; FDR p value: 1.0 × 10-2), PhenoAge acceleration (estimate: 2.31; FDR p value: 1.1 × 10-5), GrimAge (estimate: 2.54; FDR p value: 1.0 × 10-2), and GrimAge acceleration (estimate: 3.15; FDR p-value: 1.7 × 10-17). Of note, the raw and age-adjusted GrimAge surrogate DNAm protein components were significantly higher in RA cases than controls. Interestingly, the first-generation measures were associated only with women. No sex-specific effects were identified for PhenoAge or GrimAge accelerations. In this cross-sectional assessment, the second-generation clocks show promise as markers of biological aging, with higher epigenetic age acceleration observed in RA cases compared with healthy controls.
1
First-generation epigenetic age measures were associated with RA only among women, whereas PhenoAge and GrimAge acceleration showed no sex-specific effects.
2
In this cross-sectional study, second-generation epigenetic clocks showed promise as markers of biological aging in rheumatoid arthritis.
3
RA cases showed significantly higher PhenoAge acceleration (estimate 2.31), GrimAge (estimate 2.54), and GrimAge acceleration (estimate 3.15; FDR p=1.7 × 10⁻¹⁷).
4
Raw and age-adjusted GrimAge surrogate DNA methylation protein components were significantly higher in rheumatoid arthritis cases than controls.
5
Rheumatoid arthritis was significantly associated with lower Horvath 2013 and 2018 age acceleration, but higher extrinsic age acceleration after adjustment for sex and smoking.
6
This study provides the first comparative assessment of associations between multiple DNA methylation-based epigenetic aging measures and rheumatoid arthritis prevalence.

Adults with and without rheumatoid arthritis (RA), assessed using 450K DNA methylation profiles

Associations between rheumatoid arthritis prevalence and epigenetic age estimates and age-acceleration measures

Publication Details
Publication Date
2023-09-12
Journal
Publisher
ISSN
Cited by
20
Access Type
Author Information
Authors
Tracie Culp Harrison
Nandini Mukherjee
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%